- Posts by Julianna Dzwierzynski
AssociateAttorney Julianna Dzwierzynski supports health care providers with their strategic corporate transactions and regulatory compliance.
Julianna assists physician practices, hospitals, and other health care providers with ...
On August 30, an official at the United States Department of Health and Human Services (HHS) released one of the most significant announcements made at the federal level concerning marijuana reclassification. In a letter dated August 29, 2023, Rachel Levine (HHS Assistant Secretary for Health), provided a formal recommendation to Anne Milgrim (Agency Administrator) at the United States Drug Enforcement Agency (DEA) to reclassify cannabis from a Schedule I drug to a Schedule III drug under the Federal Controlled Substances Act (CSA).
A DEA spokesperson confirmed the department ...
Blog Editors
Recent Updates
- Governing Health AI Development and Adoption: Insights from HHS’s Recently Announced Strategy to Promote AI in Healthcare
- Stranger Things: New FDA Updates Flip Expectations for the Med Tech Industry in 2026 Upside Down
- The DOJ’s Bulk Sensitive Data Rule and Your Obligation to “Know Your Vendor”
- ACCESS Model: CMMI’s New Technology-Enabled Chronic Care Model
- Courts and CMS So Far Agree: States Are Preempted from Acting on MA Plan Marketing